Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Pancreatic Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Prostatic Neoplasms 1 Pancreatic Cyst 1 Liver Neoplasms 1 Glioblastoma 1 Disease 1 Depression 1 Colorectal Neoplasms 1 Camurati-Engelmann Syndrome 1 Breast Cancer Female 1 Brain Neoplasms 1 Astrocytoma 1 Anxiety Disorders 1

Interventions

Therapeutics 9 Psychiatric Rehabilitation 9 Music Therapy 8 Cognitive Behavioral Therapy 7 Mindfulness 6 Surveys and Questionnaires 5 Counseling 5 Acupuncture Therapy 5 Standard of Care 4 Mindfulness-Based Stress Reduction 4 Methods 4 Imagery, Psychotherapy 4 Early Intervention, Educational 4 Autogenic Training 4 Art Therapy 4 Therapeutic Touch 3 Psychosocial Intervention 3 Psilocybin 3 Mindfulness-Based Cognitive Therapy 3 Massage 3 Hypnosis 3 Exercise 3 Control Groups 3 Aromatherapy 3 Acceptance and Commitment Therapy 3 Yoga 2 Touch 2 Observation 2 Niacin 2 Gabapentin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Anxiety Disorders × Drug Delivery Systems × Clear all

NCT01701284 2023-11-18

rTMSinCP

Northwestern University

Phase NA Completed

Anxiety Disorders, Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡